NEW YORK (GenomeWeb) – Ag-bio firm Arcadia Biosciences announced today that has it acquired a worldwide, nonexclusive license to the Broad Institute's intellectual property on CRISPR-Cas9 genome-editing technology.

According to Arcadia, the research-use license allows it to use the patented technology to develop nutritional and agricultural productivity traits in its core crops. Additional terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.